ATOSSA THERAPEUTICS, INC. Class of Warrant or Right, Outstanding
ATOSSA THERAPEUTICS, INC. (ATOS) had Class of Warrant or Right, Outstanding of 0 shares as of 2025-12-31, per its 10-K filed 2026-03-25.
Financial Statements › Notes › Other Liabilities
us-gaap:ClassOfWarrantOrRightOutstanding · last filed 2026-03-25
- 2025-12-31: Class of Warrant or Right, Outstanding 0.00 shares.
- 2025-09-30: Class of Warrant or Right, Outstanding 0.00 shares.
- 2025-06-30: Class of Warrant or Right, Outstanding 15.03M shares.
- 2025-03-31: Class of Warrant or Right, Outstanding 17.84M shares.
| Period end | Class of Warrant or Right, Outstanding | Class of Warrant or Right, Outstanding as first filed |
|---|---|---|
| 2025-12-31 | 0.00 shares 10-K · filed 2026-03-25 | |
| 2025-09-30 | 0.00 shares 10-Q · filed 2025-11-12 | |
| 2025-06-30 | 15.03M shares 10-Q · filed 2025-08-12 | |
| 2025-03-31 | 17.84M shares 10-Q · filed 2025-05-13 | |
| 2024-12-31 | 17.84M shares 10-K · filed 2025-03-25 | |
| 2024-09-30 | 21.21M shares 10-Q · filed 2024-11-12 | |
| 2024-06-30 | 21.21M shares 10-Q · filed 2024-08-12 | |
| 2024-03-31 | 21.31M shares 10-Q · filed 2024-05-13 | |
| 2023-12-31 | 21.51M shares 10-K · filed 2024-04-01 | |
| 2023-09-30 | 21.52M shares 10-Q · filed 2023-11-13 | |
| 2023-06-30 | 21.52M shares 10-Q · filed 2023-08-14 | |
| 2023-03-31 | 21.52K shares 10-Q · filed 2023-05-15 | |
| 2022-12-31 | 21.52K shares 10-K · filed 2023-03-22 | |
| 2022-09-30 | 21.52M shares 10-Q · filed 2022-11-07 | |
| 2022-06-30 | 21.52M shares 10-Q · filed 2022-08-08 | |
| 2022-03-31 | 22.28M shares 10-Q · filed 2022-05-09 | |
| 2021-12-31 | 22.28M shares 10-K · filed 2022-02-28 | |
| 2021-09-30 | 22.28M shares 10-Q · filed 2021-11-15 | |
| 2021-06-30 | 22.57M shares 10-Q · filed 2021-08-13 | |
| 2021-03-31 | 27.66M shares 10-Q · filed 2021-05-14 | |
| 2020-12-31 | 11.57M shares 10-K · filed 2021-03-31 | |
| 2019-12-31 | 1.07M shares 10-K · filed 2020-03-26 | |
| 2019-09-30 | 1.07M shares 10-Q · filed 2019-11-13 | |
| 2019-06-30 | 1.07M shares 10-Q · filed 2019-08-13 | |
| 2019-03-31 | 1.07M shares 10-Q · filed 2019-05-13 | |
| 2018-12-31 | 3.88M shares 10-K · filed 2019-03-28 | |
| 2018-09-30 | 4.32M shares 10-Q · filed 2018-11-14 | |
| 2018-06-30 | 4.76M shares 10-Q/A · filed 2018-11-13 | |
| 2018-03-31 | 914.78K shares 10-Q · filed 2018-05-14 | |
| 2017-12-31 | 0.00 shares 10-K · filed 2019-03-28 | 10.98M shares 10-K · filed 2018-03-08 |
| 2017-09-30 | 380.56K shares 10-Q · filed 2017-11-13 | |
| 2017-06-30 | 3.27M shares 10-Q · filed 2017-08-14 | |
| 2017-03-31 | 402.23K shares 10-Q · filed 2017-05-11 | |
| 2016-12-31 | 0.00 shares 10-K · filed 2019-03-28 | 402.23K shares 10-K · filed 2017-03-16 |
| 2016-09-30 | 402.23K shares 10-Q/A · filed 2017-03-21 | |
| 2016-06-30 | 6.03M shares 10-Q/A · filed 2017-03-21 | |
| 2016-03-31 | 6.03M shares 10-Q/A · filed 2017-03-21 | |
| 2015-12-31 | 6.03M shares 10-K · filed 2016-03-30 | |
| 2015-09-30 | 8.24M shares 10-Q · filed 2015-11-12 | |
| 2015-06-30 | 9.64M shares 10-Q · filed 2015-08-06 | |
| 2013-09-30 | 4.78M shares 10-Q · filed 2013-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |